Trial Profile
The Efficacy and Safety of Nicotinic Acid in the Hemodialysis Patients With Hyperphosphatemia
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Niacin (Primary)
- Indications Hyperphosphataemia
- Focus Therapeutic Use
- Acronyms NAHPH
- 21 Jul 2016 New trial record